| Literature DB >> 35386741 |
Paulina Śmigielska1, Justyna Czarny1, Jacek Kowalski2, Aleksandra Wilkowska1, Roman J Nowicki1.
Abstract
Eosinophilic fasciitis is a rare connective tissue disease of unknown etiology. Therapeutic options include high-dose corticosteroids and other immunosuppressive drugs. We present a typical eosinophilic fasciitis case, which did not respond to first-line treatment, but improved remarkably after infliximab administration. This report demonstrates that in case of initial treatment failure, infliximab might be a relatively safe and effective way of eosinophilic fasciitis management.Entities:
Keywords: Eosinophilic fasciitis; infliximab; monoclonal antibody; scleroderma-like disorders
Year: 2021 PMID: 35386741 PMCID: PMC8892936 DOI: 10.1177/23971983211004399
Source DB: PubMed Journal: J Scleroderma Relat Disord ISSN: 2397-1983